PortfoliosLab logoPortfoliosLab logo
PPH vs. FPHAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PPH vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Pharmaceutical ETF (PPH) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PPH achieves a 8.50% return, which is significantly lower than FPHAX's 12.79% return. Over the past 10 years, PPH has underperformed FPHAX with an annualized return of 7.99%, while FPHAX has yielded a comparatively higher 11.56% annualized return.


PPH

1D
-1.08%
1M
-0.89%
6M
4.81%
YTD
8.50%
1Y
33.42%
3Y*
13.78%
5Y*
10.23%
10Y*
7.99%
ALL TIME*
5.76%

FPHAX

1D
-1.65%
1M
-4.52%
6M
10.36%
YTD
12.79%
1Y
48.98%
3Y*
19.23%
5Y*
12.98%
10Y*
11.56%
ALL TIME*
9.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$0.00$0.00$0.00
$23.32M$26.79M$26.37M

PPH vs. FPHAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PPH
VanEck Pharmaceutical ETF
8.50%22.00%8.05%6.95%2.64%17.79%5.49%19.39%-5.89%15.23%
FPHAX
Fidelity Select Pharmaceuticals Portfolio
12.79%30.41%9.39%12.54%0.94%11.79%11.16%31.73%5.41%10.70%

Correlation

The correlation between PPH and FPHAX is 0.86, meaning they have usually moved in the same direction, including during past declines.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.86

Correlation (3Y)
Balances recent behavior with more history.

0.85

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.86

Correlation (10Y)
Provides a long-term view across more market conditions.

0.88

Correlation (All Time)
Calculated using the full available price history since Jun 18, 2001

0.89

The correlation between PPH and FPHAX has been stable across timeframes, ranging from 0.85 to 0.89 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PPH vs. FPHAX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PPH
PPH Risk / Return Rank: 8383
Overall Rank
PPH Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
PPH Sortino Ratio Rank: 9090
Sortino Ratio Rank
PPH Omega Ratio Rank: 8383
Omega Ratio Rank
PPH Calmar Ratio Rank: 8686
Calmar Ratio Rank
PPH Martin Ratio Rank: 6969
Martin Ratio Rank

FPHAX
FPHAX Risk / Return Rank: 9090
Overall Rank
FPHAX Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
FPHAX Sortino Ratio Rank: 8989
Sortino Ratio Rank
FPHAX Omega Ratio Rank: 8383
Omega Ratio Rank
FPHAX Calmar Ratio Rank: 9696
Calmar Ratio Rank
FPHAX Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PPH vs. FPHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PPHFPHAXDifference
Sharpe ratioReturn per unit of total volatility

-0.29

Sortino ratioReturn per unit of downside risk

-0.20

Omega ratioGain probability vs. loss probability

1.35

1.38

-0.03

Calmar ratioReturn relative to maximum drawdown

3.36

4.53

-1.17

Martin ratioReturn relative to average drawdown

8.51

13.77

-5.26

PPH vs. FPHAX - Sharpe Ratio Comparison

The current PPH Sharpe Ratio is 2.02, which is comparable to the FPHAX Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of PPH and FPHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PPH vs. FPHAX - Drawdown Comparison

The maximum PPH drawdown since its inception was -51.45%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for PPH and FPHAX.


Loading charts...

Drawdown Indicators


PPHFPHAXDifference

Max Drawdown

Largest peak-to-trough decline

-51.45%

-38.26%

-13.19%

Max Drawdown (1Y)

Largest decline over 1 year

-10.76%

-10.33%

-0.43%

Max Drawdown (3Y)

Largest decline over 3 years

-18.06%

-28.82%

+10.76%

Max Drawdown (5Y)

Largest decline over 5 years

-20.26%

-28.82%

+8.56%

Max Drawdown (10Y)

Largest decline over 10 years

-29.70%

-28.82%

-0.88%

Current Drawdown

Current decline from peak

-2.79%

-5.24%

+2.45%

Average Drawdown

Average peak-to-trough decline

-17.22%

-9.13%

-8.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.24%

3.41%

+0.83%

Volatility

PPH vs. FPHAX - Volatility Comparison

VanEck Pharmaceutical ETF (PPH) and Fidelity Select Pharmaceuticals Portfolio (FPHAX) have volatilities of 6.53% and 6.43%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PPHFPHAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.53%

6.43%

+0.10%

Volatility (6M)

Calculated over the trailing 6-month period

13.52%

15.25%

-1.73%

Volatility (1Y)

Calculated over the trailing 1-year period

18.18%

20.24%

-2.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.42%

18.35%

-2.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.05%

17.93%

-0.88%

PPH vs. FPHAX - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is lower than FPHAX's 0.67% expense ratio.


Dividends

PPH vs. FPHAX - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 1.97%, less than FPHAX's 4.93% yield.


PositionTTM20252024202320222021202020192018201720162015
FPHAX
Fidelity Select Pharmaceuticals Portfolio
4.93%5.68%1.90%8.08%5.18%11.09%8.85%8.33%1.65%1.62%1.07%12.63%
PPH
VanEck Pharmaceutical ETF
1.97%1.78%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%

Frequently Asked Questions


PPH and FPHAX have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PPH has higher volatility (6.53%) compared to FPHAX (6.43%). In terms of maximum drawdown, PPH dropped -51.45% vs FPHAX's -38.26%.

FPHAX currently has the higher Sharpe Ratio (2.32 vs 2.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PPH and FPHAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer